tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market
Want to see CPRX full AI Analyst Report?

Catalyst Pharma (CPRX) Blogger Opinions & Sentiment

2,542 Followers

Blogger Sentiment

Bullish: 83.33%
Sector Average
Bullish
CPRX Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
33% Zacks
17% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Best Value Stocks to Buy for March 31st
Zacks
Catalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount
Investing
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
Zacks
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of CPRX?
Seeking Alpha’s Third Avenue Management has a Bullish Sentiment.
    What do Motley Fool contributors think of CPRX?
    Currently there's no blogger sentiment for CPRX.
    What Is CPRX’s Blogger Sentiment?
    CPRX’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for CPRX?
      The most recent blogger prediction for CPRX was made by Third Avenue Management, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited